Journals / Türk Biyokimya Dergisi / 2009 / Cilt: 34 - Sayı: 4

Identification of Hb hamadan mutation (β56 GGC→CGC, (D7) Gly→Arg) which was detected in Çukurova region for the first time with microarray method

Çukurova bölgesinde ilk defa saptanan Hb hamadan (β56 GGC→CGC, (D7) Gly→Arg) mutasyonunun mikroarray yöntemiyle tanımlanması

Pages
256–259
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Heterozygous Hemoglobin Hamadanand Hemoglobin Hamadan combined with IVS I-110 mutation was found by usingthe designed reporter.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemoglobin Hamadan is the result of a glycine to arginine change due toGGC→CGC mutation at codon 56 of the beta globin gene.
📊
Key Findings & Data:Until today, togetherwith HbS which is the most common mutation in Turkey, fourty nine abnormalhemoglobin mutations have been reported such as rarely observed Hb Hamadanwhich does not show any clinical symptom.
💡
Conclusion & Impact:Heterozygous Hemoglobin Hamadanand Hemoglobin Hamadan combined with IVS I-110 mutation was found by usingthe designed reporter.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemoglobin Hamadan is the result of a glycine to arginine change due toGGC→CGC mutation at codon 56 of the beta globin gene. Until today, togetherwith HbS which is the most common mutation in Turkey, fourty nine abnormalhemoglobin mutations have been reported such as rarely observed Hb Hamadanwhich does not show any clinical symptom. In this study, for the first time, we designed a reporter to Hb Hamadan for Nanogen microarray instrument, by using thebase change causing to the mutation of a case which was determined to have anabnormal hemoglobin by sequence analysis. Heterozygous Hemoglobin Hamadanand Hemoglobin Hamadan combined with IVS I-110 mutation was found by usingthe designed reporter.

Özet

Beta globin geninin 56.cı kodonunda GGC→CGC değişimi sonucunda glisin yerine arjinin amino asiti geçmekte ve hemoglobin Hamadan ortaya çıkmaktadır. Bugüne kadar Türkiye’de en yaygın olarak gözlenen HbS mutasyonu yanında nadirolarak gözlenen ve klinik olarak herhangi bir bulgu göstermeyen Hb Hamadangibi 49 anormal hemoglobin mutasyonu bildirilmiştir. Bu çalışmada dizi analizi ileanormal hemoglobin olduğu belirlenen olgunun mutasyona neden olan baz değişimi kullanılarak ilk defa Nanogen mikroarray aleti için Hb Hamadan mutasyonunaözgü tanımlayıcı tasarımı yapılmıştır. Tasarlanan tanımlayıcılar sayesinde heterozigot ve IVS I-110 ile kombine olan Hb Hamadan mutasyonu belirlenmiştir.

🔖

Cite This Article

YILDIZ, M. Ş., AKSOY, K., ARIYÜREK, Y. S. (2022). Identification of Hb hamadan mutation (β56 GGC→CGC, (D7) Gly→Arg) which was detected in Çukurova region for the first time with microarray method. Türk Biyokimya Dergisi, Cilt: 34 - Sayı: 4, 256–259. https://ajindex.com/articles/621329

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Lukens JN, Lee GR. (1993)The Abnormal Hemoglobins. In: Wintrobe’s Clinical Hemalology, Eds Lee GR, Bithell CT, Foester J,Athens JW, Lukens JN. Lee and Febiger Com, Pennsyvania
  2. Kılınç Y. (2006) Hemoglobinopathies in Turkey. Turkish J Hematol 23:214-21 [3] Altay Ç. (2002) Abnormal hemoglobins in Turkey. Turkish J Hemotol 19(1): 63-74
  3. Akar E, Akar N. (2007) A review of abnormal hemoglobins in Turkey. Turkish J Hematol 24:143-145 [5] Dincol G, Aksoy M, Dincol K, Kutlar A, Wilson JB, Huisman TH. (1984) Hemoglobin Hamadan or alpha 2 beta 256(D7) GlyoArg in a Turkish family. Hemoglobin 8(4): 423-5
  4. Rahbar S, Nowzari G, Haydari H, Daneshmand P. (1975) Haemoglobin Hamadan: alpha-2A beta-2 56 (D7) glycine yields arginine. Biochim Biophys Acta 379(2): 645-8
  5. Akar E, Özdemir S, Timur İS, Akar N. (2003) First Observation of Homozygous Hemoglobin Hamadan (B 56 (D7) GLY-ARG) and Beta Thalassemia (-29 G>A)- Hemoglobin Hamadan Combination in a Turkish Family. Am J Hematol 74:280–282
  6. Altunkılıç S. (2004) Anamur yöresinin b-talasemi mutasyon tiplendirilmesi. Yüksek Lisans Tezi, ÇÜ Sağlık Bilimleri Enstitüsü Nanogen guide
  7. Nanogen guide
  8. Bowden JR, Brennan PA. (2004) DNA microarray technology: insights for oral and maxillofacial surgeons. Br J Oral Maxillofac Surg 42: 542-545
  9. Tadmouri G, Başak N. (2001) β thalassemia in Turkey: A review of the clinical, epidemiological, molecular, and evolutionary aspects. Hemoglobin 25(2): 227-239
  10. Yüregir GT, Arpacı A, Aksoy K, Azar AM, Tanrıverdi K. (1993) Çukurova’da beta talasemik gen sıklığının taranması ve mutasyon odaklarının belirlenmesi. TÜBİTAK, TAG:0758 [13] Yüregir GT, Arpacı A, Aksoy K, Tuli A, Dikmen N, Özgünen T, Kılınç Y. (1995) Population at risk for hemoglobinopathies in Çukurova. Türkiye: Need for prenatal diagnosis. Ann Med Sci 4:61-60
  11. Cremonesi L, Ferrari M, Giordano PC, Harteveld CL, Kleanthous M, Papasavva T, Patrinos GP, Traeger-Synodinos J. (2007) An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 31(3): 289-311
  12. Foglieni B, Galbiati S, Ferrari M, Cremonesi L. (2008) Prenatal Diagnosis, s. 169-182, Humana Press, Totowa NJ.